Skip to main content

Peer Review reports

From: Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis

Original Submission
10 Jul 2018 Submitted Original manuscript
31 Aug 2018 Reviewed Reviewer Report - Andras Bikov
7 Oct 2018 Reviewed Reviewer Report - G. J. Braunstahl
28 Dec 2018 Author responded Author comments - Takanori Numata
Resubmission - Version 2
28 Dec 2018 Submitted Manuscript version 2
15 Aug 2019 Reviewed Reviewer Report - Andras Bikov
21 Aug 2019 Reviewed Reviewer Report - G. J. Braunstahl
27 Aug 2019 Author responded Author comments - Takanori Numata
Resubmission - Version 3
27 Aug 2019 Submitted Manuscript version 3
8 Sep 2019 Reviewed Reviewer Report - Andras Bikov
26 Sep 2019 Author responded Author comments - Takanori Numata
Resubmission - Version 4
26 Sep 2019 Submitted Manuscript version 4
Publishing
27 Sep 2019 Editorially accepted
12 Oct 2019 Article published 10.1186/s12890-019-0952-1

You can find further information about peer review here.

Back to article page